Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder-Reference-Cited by-同舟云学术

Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Published:2018-05 Issue:5 Volume:32 Page:455-467
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Banaschewski Tobias,Johnson Mats,Nagy Peter,Otero Isabel Hernández,Soutullo César A.,Yan Brian,Zuddas Alessandro,Coghill David R.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Link

http://link.springer.com/article/10.1007/s40263-018-0514-8/fulltext.html

Reference42 articles.

1. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder: the MTA Cooperative Group. Multimodal treatment study of children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073–86.

2. Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, et al. European clinical guidelines for hyperkinetic disorder: first upgrade. Eur Child Adolesc Psychiatry. 2004;13(Suppl 1):I7–30.

3. Huang YS, Tsai MH. Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge. CNS Drugs. 2011;25(7):539–54.

4. Chan E, Fogler JM, Hammerness PG. Treatment of attention-deficit/hyperactivity disorder in adolescents: a systematic review. JAMA. 2016;315(18):1997–2008.

5. Shire US Inc. Vyvanse® (lisdexamfetamine dimesylate): US prescribing information. Revised Jan 2017.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Pediatric Anti-obesity Medications—Current Landscape and Approach to Prescribing;Current Obesity Reports;2024-04-30

2. The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project;Journal of Attention Disorders;2024-02-17

3. Therapeutic Use of Dopamine Enhancers (Stimulants);Tasman’s Psychiatry;2024

4. Growth Trajectories in Stimulant Treated Children and Adolescents: A Qualitative Review of the Literature from Comprehensive Datasets and Registries;Journal of Child and Adolescent Psychopharmacology;2023-11-01

5. Growth Trajectories in Stimulant-Treated Children Ages 6 to 12: An Electronic Medical Record Analysis;Journal of Developmental & Behavioral Pediatrics;2023-02